Top Markets
#1 Gama Token Gama Token +9.13%
#2 Audiera Audiera +4.96%
#3 Akedo Akedo +4.75%
#4 Nexpace Nexpace +4.13%
#5 Cross Cross +3.76%
#6 Ontology Gas Ontology Gas +3.64%
#7 Holoworld Holoworld +3.39%
#8 Velvet Velvet +3.01%
#9 Humanity Humanity +2.82%
#10 Perle Perle +2.77%
Coin of the day
Gama Token Gama Token
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Rang in Aktien #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Aktienkurs
$0.20529272
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$2.54M
Veränderung (1 Tag)
0.11%
Veränderung (1 Jahr)
-49.29%
Land
SE
Handel Qlife Holding AB (publ) (QLIFE)

Kategorie

Healthcare
P/B-Verhältnis für Qlife Holding AB (publ) (QLIFE)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Qlife Holding AB (publ) beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Qlife Holding AB (publ) von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 -
US